Biopharma

EMEA-003497-PIP01-23

EMEA-003497-PIP01-23

EMEA-003419-PIP01-23

EMEA-003419-PIP01-23

Rovi warns analyst profit consensus is too high, cites ...

Spanish drugmaker Rovi warned this month that analyst consensus estimates for it...

Pfizer outlines Talzenna's survival benefit in bid for ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to furth...

EMEA-003025-PIP03-23-M01

EMEA-003025-PIP03-23-M01

Fierce Biotech Fundraising Tracker '25: Newleos emerges...

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

EMEA-003071-PIP02-23

EMEA-003071-PIP02-23

Common antibiotic could treat inflammatory bowel disease

An antibiotic used to treat infective diarrhoea could be an effective drug for a...

Overview of the current regulatory testing requirements...

Overview of the current regulatory testing requirements for medicinal products f...

Overview of the current regulatory testing requirements...

Overview of the current regulatory testing requirements for veterinary medicinal...

CDMO Axplora reveals €50M expansion at French productio...

Axplora, a German CDMO that specializes in API small molecule and ADC production...

Roche scores FDA nod for Evrysdi tablets, bolstering co...

The FDA on Wednesday gave the thumbs up to a tablet formulation of Roche's Evrys...

The biotech news stories you need to read today

The risk of pharma bribery, the risk of brain drain, and other risks (and reward...

Early Childhood Sun Exposure Linked to Lower Risk for P...

WEDNESDAY, Feb. 12, 2025 -- Greater prenatal and early childhood sun exposure i...

People with alcohol-use disorder drank less on Ozempic,...

And other health news stories to read this Thursday.

STAT+: Pharmalittle: We’re reading about fears of a Tru...

Scientists fear disruptive Trump policies could lead to a brain drain and underm...

Quarterly System Demo – Q1 2025, Online, European Medic...

Quarterly System Demo – Q1 2025, Online, European Medicines Agency, Amsterdam, t...

Amgen ends Ideaya cancer combination trial after partne...

Amgen and Ideaya Biosciences are winding down their cancer combination study, cl...

Aardvark heads to Nasdaq with $94M IPO to fund more app...

Obesity-focused Aardvark Therapeutics is heading to the Nasdaq this morning in a...

EMEA-003233-PIP01-22

EMEA-003233-PIP01-22

EMA Veterinary Innovation Day, Online, European Medicin...

EMA Veterinary Innovation Day, Online, European Medicines Agency, Amsterdam, the...

Agenda - EMA Veterinary Innovation Day - March 2025

Agenda - EMA Veterinary Innovation Day - March 2025

Opinion/decision on a Paediatric investigation plan (PI...

Opinion/decision on a Paediatric investigation plan (PIP): Filsuvez, birch bark,...

Regulation (EU) 2024/568: Questions and answers clinic ...

Regulation (EU) 2024/568: Questions and answers clinic for the Human Industry st...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.